SCHEMBL7412708

SCHEMBL7412708

O=C1c2c(c3ccccc3[nH]c2=O)C(=O)N1c1cccs1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 4/20 0.43
CDK5R1 Q15078 4/20 0.43
KMT2A Q03164 3/20 0.41
LMNA P02545 3/20 0.41
KDM4E B2RXH2 3/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HSD17B10 Q99714 2/20 0.41
PARP1 P09874 2/20 0.41
TNKS O95271 2/20 0.41
TNKS2 Q9H2K2 2/20 0.41
CYP1A2 P05177 1/20 0.41
GPR3 P46089 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
PARP15 Q460N3 1/20 0.41
MAPT P10636 3/20 0.40
MAPK14 Q16539 2/20 0.40
POLB P06746 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7415475 0.77 MAPT (0.49) CDK5CDK5R1KMT2ALMNAKDM4E
SCHEMBL7415495 0.76 KDM4E (0.40) CDK5CDK5R1KMT2ALMNAKDM4E
SCHEMBL7409290 0.75 MAPK14 (0.53) CDK5CDK5R1KMT2ALMNAKDM4E
SCHEMBL7406002 0.72 MAPK14 (0.44) KMT2ALMNAKDM4EMEN1ALDH1A1
SCHEMBL7407990 0.72 MAPK14 (0.53) KMT2ALMNAKDM4EMEN1ALDH1A1
SCHEMBL7416744 0.72 PARP1 (0.49) CDK5CDK5R1KMT2ALMNAKDM4E
SCHEMBL7415108 0.72 CASP3 (0.55) KMT2ALMNAKDM4EMEN1ALDH1A1
SCHEMBL7412697 0.72 ADORA3 (0.51) KMT2ALMNAKDM4EMEN1ALDH1A1
SCHEMBL7414758 0.69 HTT (0.54) CDK5CDK5R1KDM4EHSD17B10PARP1
SCHEMBL7410394 0.69 ADORA3 (0.54) KMT2ALMNAKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1994026741-A1 CERTAIN PYRROLOQUINOLINONES; A NEW CLASS OF GABE BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1994-11-24 WO claimed
US-5243049-A Gamma-aminobutyric acid antagonist NEUROGEN CORPORATION (US) 1993-09-07 US claimed
US-5908932-A Certain pyrroloquinolinones; a new class of GABA brain receptor NEUROGEN CORPORATION (US) 1999-06-01 US disclosed
US-5604235-A DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP AND SEIZURE DISORDERS, BENZODIAZEPINE OVERDOSE; ENHANCEMENT OF MEMORY NEUROGEN CORPORATION (US) 1997-02-18 US disclosed
US-5243049-A Gamma-aminobutyric acid antagonist NEUROGEN CORPORATION (US) 1993-09-07 US disclosed